(2026-01-06 01:49:00) – A study previously used to defend the weedkiller Roundup has been retracted, renewing concerns about the product’s safety.
A scientific paper that supported the safety of glyphosate,the active ingredient in Roundup,was withdrawn by the journal after questions arose regarding the study’s origins and potential conflicts of interest.
- A study assessing the safety of glyphosate was retracted from the journal Environmental Sciences Europe.
- The retraction followed the revelation of ties between the study’s authors and Roundup manufacturer Bayer.
- The progress adds to ongoing debate and litigation surrounding the potential health risks associated wiht glyphosate exposure.
study Retracted Amid Industry Ties
the peer-reviewed study, published in 2023, concluded that glyphosate was not harmful to human health, a finding that had been cited in defense of the widely used herbicide, according to the New York Times.
Environmental Sciences Europe retracted the study on January 5, 2026, after discovering that the research was funded by Bayer and that the authors had not fully disclosed their financial connections to the company, Straight arrow News reported.
Fresh Controversy Over Glyphosate
Glyphosate is one of the most widely used herbicides in the world, and it’s safety has been the subject of intense debate for years. The International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans” in 2015, while regulatory agencies in the United States and Europe have maintained that it is safe when used as directed, ConsumerAffairs noted.
Bayer,which acquired Monsanto – the original manufacturer of Roundup – has faced thousands of lawsuits alleging that glyphosate causes cancer.The company has settled many of these cases, but litigation continues.
The retraction of the study is likely to fuel further scrutiny of glyphosate and its potential health effects. The the-star.co.ke reported that the retraction raises questions about the integrity of scientific research funded by the agricultural industry.
Why did this happen? The study was retracted because of serious concerns about its integrity. Environmental Sciences Europe discovered undisclosed financial ties between the study’s authors and Bayer, the manufacturer of Roundup. This lack of transparency raised questions about the objectivity of the research.
Who was involved? Key players include Environmental Sciences Europe, the journal that retracted the study; Bayer, the funder and manufacturer of Roundup; the study’s authors, whose financial connections were not fully disclosed; and the International Agency for research on Cancer (IARC), which previously classified glyphosate as potentially carcinogenic.
what was the study’s claim? The retracted study concluded that glyphosate was not harmful to human health. This finding was used to defend roundup against claims that it causes cancer.
How did it end? The study was officially retracted by Environmental Sciences Europe on January 5, 2026. The retraction is expected to intensify the debate surrounding glyphosate’s safety and could impact ongoing litigation against Bayer. The journal stated, “the article was retracted as of serious concerns about the integrity of the research,” a statement from environmental Sciences Europe read, as reported by The New York Times.
